Status:
COMPLETED
MINI Bypass Versus Roux-en-Y Bypass: Differences in HOrmonal Secretions at 2 Years of Surgery
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Société Francophone Nutrition Clinique et Métabolisme
Conditions:
Bariatric Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Gastric bypass with omega loop technic (OLGB) seems to be as effective as gastric bypass roux-en-Y (RYGB the reference) for the management of obesity and type 2 diabetes, but with less early surgical ...
Detailed Description
In the treatment of obesity associated with type 2 diabetes, there is still few informations comparing the gastric bypass roux-en-Y (RYGB), the reference method, and the bypass in Omega (OLGB). The ef...
Eligibility Criteria
Inclusion
- Roux en Y gastric bypass or omega loop gastric bypass at two years of the surgery (6 months more or less)
- 18 years minimum
- weight \> 40kg
Exclusion
- Type 1 diabetes diagnosed with the positivity of anti Glutamate Acid Decarboxylase (GAD) or anti Ia2
- Treatment with Insulin, Glucagon Like Peptide 1 (GLP1) or anti-DiPeptidyl Peptidase-4 (DPP4) during the study
- Unbalanced type 2 diabetes : HbA1c \> 8%
- Anemia with hemoglobin \< 7g/dl
- Gut inflammatory disease ; infectious disease, cancer, iatrogenic disease, auto-immune disease
- Pregnant or breastfeeding women
- allergy to Carmin (E120)
- participation to another clinical trial
- patient under legal protection
Key Trial Info
Start Date :
April 4 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 14 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03482895
Start Date
April 4 2018
End Date
May 14 2019
Last Update
September 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AP-HP - Hôpital Européen Georges-Pompidou
Paris, Île-de-France Region, France, 75015